HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection

HIV1+HCV+HBV SerPlBld Donr NAA+prb

Definition

This term is created for but not restricted in use to the Procleix® Ultrio® assay, which is FDA-approved to screen for human immunodeficiency virus type 1 (HIV-1) RNA, hepatitis B virus (HBV) RNA, and hepatitis C virus (HCV) RNA in specimens from individual donors. This test is intended for determining the eligibility of donors and is not intended for clinical or diagnostic evaluation of patients.

3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Donr; HBV; HCV; Hep; Hep B; Hep B virus; Hep C; Hepatis; Hepatit; Hepatitis C virus; HepB; HIV; HIV 1 RNA+HCV RNA+HBV; HIV 1+HCV RNA+HBV DNA; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; PlasBld; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood

34 further terms